Advisory Services Network, LLC Inmune Bio, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$6.13 - $7.96 $551 - $716	90 New	90 $0
Q3 2021 Nov 05, 2021	SELL	$14.13 - $27.85 $43,916 - $86,557	-3,108 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$9.29 - $19.33 $28,873 - $60,077	3,108 New	3,108 $55,000
Q4 2020 Feb 09, 2021	SELL	$7.51 - $17.22 $10,236 - $23,470	-1,363 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.92 - $15.75 $6,705 - $21,467	1,363 New	1,363 $14,000
Q1 2020 May 15, 2020	SELL	$2.21 - $6.15 $1,105 - $3,075	-500 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$3.56 - $6.1 $1,780 - $3,050	500 New	500 $3,000

5.92M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $79.3M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.